Abstract: A radio frequency device, for example, a VHF (very-high-frequency) or UHF (ultra-high-frequency) filter, combiner or a microwave band device filter, having a temperature compensation structure, used for telecommunication applications, is disclosed. Thermal frequency drift is minimized by suitably selecting materials of different thermal heat expansion properties and careful placement of different components of a temperature compensation structure.

Abstract: An ultrasonic resistance welding apparatus 10 contains a resistance spot welding apparatus 15, a first electrode 16 and a vibrable second electrode 18, the vibrable second electrode 18 in operable communication with an ultrasonic transducer 12, whereby the ultrasonic transducer 12 selectively imparts vibratory energy to the vibrable second electrode 18 based on signals from a controller 32. The vibrable second electrode 18 may be tuned or designed to resonate within 2.5% of an operating frequency of the ultrasonic transducer 12. During operation of the welding apparatus 10, a tip 19 of the second vibrable electrode 18 may be positioned at an anti-nodal point 38 of the vibratory energy and the vibrable second electrode 18 may be attached to the resistance spot welding apparatus 15 at a nodal plane 36 of the vibratory energy. A process for employing the apparatus 10 is also presented.

Abstract: The present application provides tricyclic urea compounds that modulate the activity of the V617F variant of JAK2, which are useful in the treatment of various diseases, including cancer.

Abstract: Methods and systems are described herein relate to automatic channel identification of high-bandwidth memory channels and subchannel generation. An HBM channel identification system may perform a sequence of operations to identify HBM channels within a netlist of an interposer: channel dimension prediction, channel bounding box prediction, channel orientation derivation, subchannel partition, and subchannel routing region creation. In one example, an HBM channel identification method includes identifying candidate nets within a netlist. A bounding box that includes one or more nets of the candidate nets is determined. Once the bounding box is determined, the orientation of the box is determined and used to determine a pattern of bumps within the bounding box. Finally, a subchannel is generated based on the pattern of bumps.

Abstract: The disclosure relates to a pharmaceutical composition containing an anti-TROP2 antibody drug conjugate and its application. Specifically, the disclosure relates to a pharmaceutical composition comprising an antibody drug conjugate in a buffer. The pharmaceutical composition has good stability.

Abstract: The present invention provides an FFR determination method and apparatus based on multi-modal medical image, a device, and a medium. The method includes: obtaining an intravascular image comprising a blood vessel segment of interest; obtaining an extravascular image comprising a blood vessel segment to be detected, where the blood vessel segment to be detected at least partially coincides with the blood vessel segment of interest; performing registration on the intravascular image and the extravascular image to obtain a registration result; and determining a target fractional flow reserve based on multi-modal medical image by using the registration result on the basis of the intravascular image and the extravascular image.

Abstract: A method is disclosed. The method includes receiving, by a server computer comprising a machine learning model, a fulfillment request including an address from an end user device operated by an end user. The method also includes determining an address type associated with the address, and performing, by the server computer, further processing based upon the address type.

Abstract: The disclosure discloses a direct-drive sand mill. In various embodiments, the direct-drive sand mill includes: a motor assembly operable to be electrically powered to generate a rotation around a motor rotor rotation axis, a sand mill main body configured to perform a sanding operation, a main shaft configured to extend from the motor assembly to the sand mill main body and to include a shaft section inside the sand mill main body, the main shaft being coaxially aligned with the motor rotor, main shaft support devices positioned at different locations along the main shaft to support the main shaft to coaxially align the motor rotor rotation axis of the motor assembly to the sand mill main body, and multiple flatness detection assemblies positioned at different locations along the main shaft to detect whether the main shaft shifts with respect to the axis of the main shaft.

Abstract: The present invention provides a pharmaceutical composition comprising a CD40 antibody or an antigen-binding fragment thereof and an acetic acid-sodium acetate buffer solution, and a use thereof. The pharmaceutical composition may further contain sugar, a non-ionic surfactant, and other excipients. The pharmaceutical composition of the present invention shows good antibody stability.

Abstract: The present application provides tricyclic urea compounds that modulate the activity of the V617F variant of JAK2, which are useful in the treatment of various diseases, including cancer.

Abstract: Methods, apparatus and systems for additive manufacturing are provided. Such may include an additive manufacturing material supply, and an energy source that heats the additive manufacturing material supply, forming a melt pool; and an ultrasonic-vibrating member positioned at a distance behind the energy source, such that the ultrasonic-vibrating member is configured to contact the melt pool on a trailing side of the energy source and provide ultrasonic acoustic cavitation and streaming effects to the additive manufacturing process.

Abstract: A method for blockchain generation is provided. The method includes: sending, by a client, transaction information to a first node device, where the transaction information includes basic information and digest information; receiving, by the client, an endorsement result sent by the first node device, where the endorsement result includes a signature generated after the first node device successfully performs transaction simulation; and if the endorsement result meets a preset transaction condition, sending, by the client, the digest information and the endorsement result to a second node device, so that the second node device sends, to the first node device the digest information to generate a complete blockchain. In this way, only the digest information is transmitted between the first node device and the second node device. Therefore, the second node device does not obtain the complete transaction information, so that information security is improved.

Abstract: An image sticking test method and an image sticking test device. The image sticking test method includes: acquiring a first correspondence between a source-drain current of a preset drive transistor and time within a first preset time after a voltage of the preset drive transistor in an array substrate is switched from a first preset voltage to a second preset voltage; acquiring a second correspondence between a source-drain current of the preset drive transistor and time within a second preset time after the voltage of the preset drive transistor is switched from a third preset voltage to the second preset voltage; and acquiring a first image sticking test curve of the array substrate according to the first correspondence, the second correspondence and an image sticking evaluation formula, where the first image sticking test curve is a correspondence between time and an image sticking evaluation value.

Abstract: Provided are a pharmaceutical composition comprising an antibody-drug conjugate, and use of the pharmaceutical composition. Specifically provided is a pharmaceutical composition, comprising an anti-claudin antibody-drug conjugate.

Abstract: Provided are a pharmaceutical composition comprising an anti-TSLP antibody and the use thereof. The pharmaceutical composition comprises an anti-TSLP antibody and a buffer.

Abstract: Provided is a pharmaceutical composition comprising an anti-connective tissue growth factor antibody. In another aspect, further provided is a use of the pharmaceutical composition comprising an anti-connective tissue growth factor antibody.

Abstract: A method includes obtaining a first preview picture collected by a camera, where an angle of view FOV of the camera is a first FOV value. The camera collects the first preview picture based on a second FOV value, and the second FOV value is less than the first FOV value. The method further includes adjusting the second FOV value to a third FOV value when it is detected that a quantity of at least one target human face in the first preview picture is greater than a first preset value, where the third FOV value is greater than the second FOV value, and the third FOV value is less than or equal to the first FOV value; and outputting an image that is photographed by the camera based on the third FOV value.

Abstract: Methods and systems are described herein relate to automatic channel identification of high-bandwidth memory channels and subchannel generation. An HBM channel identification system may perform a sequence of operations to identify HBM channels within a netlist of an interposer: channel dimension prediction, channel bounding box prediction, channel orientation derivation, subchannel partition, and subchannel routing region creation. In one example, an HBM channel identification method includes identifying candidate nets within a netlist. A bounding box that includes one or more nets of the candidate nets is determined. Once the bounding box is determined, the orientation of the box is determined and used to determine a pattern of bumps within the bounding box. Finally, a subchannel is generated based on the pattern of bumps.

Abstract: The present application provides tricyclic urea compounds that modulate the activity of the V617F variant of JAK2, which are useful in the treatment of various diseases, including cancer.

Abstract: The present invention relates to a signal peptide for reducing the end heterogeneity of a heterologous polypeptide. Specifically, the present invention relates to a signal peptide for protein expression. The present invention further relates to a recombinant polypeptide, a preparation method therefor, and a composition containing a recombinant polypeptide.